Port-site metastases after diagnostic laparoscopy in advanced ovarian cancer: a case report and a systematic review of the literature - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Port-Site Metastasis Following Diagnostic Laparoscopy in Advanced Ovarian Cancer: A Case Study and Comprehensive Literature Review

  • By

  • Orazio De Tommasi

  • Sofia Bigardi

  • Giosuè Giordano Incognito

  • Linda Modena

  • Chiara Goretti

  • Giulia Spagnol

  • Carla Ettore

  • Giuseppe Ettore

  • Marco Noventa

  • Carlo Saccardi

  • Roberto Tozzi

  • May 8, 2026

Share

  • 1

    Port-site metastases (PSM) can occur after diagnostic laparoscopy in advanced ovarian cancer, posing significant clinical challenges.

  • 2

    The incidence of PSM varies widely, reported between 1.18% and 46.7%, influenced by detection methods and study designs.

  • 3

    Risk factors for PSM include advanced FIGO stage, large-volume ascites, extensive peritoneal disease, and institutional expertise.

  • 4

    Routine port-site resection can achieve local control but increases wound-related morbidity without improving survival outcomes.

  • 5

    Diagnostic laparoscopy remains a safe and cost-effective procedure for advanced ovarian cancer when performed in specialized centers.

Original Source(s)

Port-site metastases after diagnostic laparoscopy in advanced ovarian cancer: a case report and a systematic review of the literature

  • by Orazio De Tommasi, Sofia Bigardi, Giosuè Giordano Incognito, Linda Modena, Chiara Goretti, Giulia Spagnol, Carla Ettore, Giuseppe Ettore, Marco Noventa, Carlo Saccardi, Roberto Tozzi

  • May 8, 2026

Related Content

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

  • August 31, 2026

  • 5 min
Genetic Testing in Retinoblastoma: New Applications

Liquid biopsy and molecular profiling are expanding the diagnostic and prognostic role of genetic testing in retinoblastoma.

Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis